Analysis of Revascularization in Ischemic Stroke With EmboTrap
Public ClinicalTrials.gov record NCT02488915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Study identification
- NCT ID
- NCT02488915
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Neuravi Inc.
- Industry
- Enrollment
- 228 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2015
- Primary completion
- Apr 30, 2017
- Completion
- Aug 31, 2017
- Last update posted
- Jul 12, 2018
2015 – 2017
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA | Los Angeles | California | 90095 | — |
| Good Samaritan Hospital and Regional Medical Center | San Jose | California | 95124 | — |
| University of Miami and Jackson Memorial Hospital | Miami | Florida | 33136 | — |
| Emory University School of Medicine, | Atlanta | Georgia | 30303 | — |
| Riverside Radiology and Interventional Associates | Columbus | Ohio | 43214 | — |
| St Vincent Mercy Hospital | Toledo | Ohio | 43608 | — |
| OHSU Stroke Center | Portland | Oregon | 97239 | — |
| UPMC Stroke Center | Pittsburgh | Pennsylvania | 15213 | — |
| Tennessee Interventional and Imaging Associates | Chattanooga | Tennessee | 37403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02488915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2018 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02488915 live on ClinicalTrials.gov.